The report on global autoimmune
disease diagnostics market is an in depth analysis of the segments and
sub-segments in the autoimmune disease diagnostics market. The report provides
analysis for the global as well as regional markets over the period of 2015 to
2023. According to report the global autoimmune disease diagnostics market is
expected to grow at a CAGR of 3.5% over the forecast period of 2017 - 2023.
Figure 1: Autoimmune Disease
Diagnostics Market by Value 2015 - 2023
Segments Covered
The report on global autoimmune
disease diagnostics market covers segments such as type. The type segments
include localized autoimmune disease diagnostics and systemic autoimmune
disease diagnostics.
Geographic Coverage
The report provides regional
analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each
geography is provided over the period of 2015 – 2023.
Figure 2: Autoimmune Disease
Diagnostics Market by Region, CAGR %, 2017-2023
The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific
includes China, Japan, India, South Korea, Malaysia and among others. Moreover,
The European region covers countries such as, Germany, UK, France, Spain and
Rest of Europe. The U.S. drives the growth in the North America region as it is
the largest market in the region. The Asia-pacific region offers a substantial
potential for the market growth owing to rapid growth in markets such as India
and China. The APAC region is projected to experience a growth at a CAGR of
x.x% over the period of 2017 - 2023.
Companies Profiled:
The report provides profiles of
the companies in the global autoimmune disease diagnostics market such as, Abbott
Laboratories, Siemens Healthineers, Roche Diagnostics, Beckman Coulter, Inc.,
SQI Diagnostics, Inc., EUROIMMUN AG, AESKU.Diagnostics GmbH & Co. KG, Inova
Diagnostics, Crescendo Bioscience, Inc., and bioMerieux SA.
Report Highlights:
The report provides deep insights
on demand forecasts, market trends and micro and macro indicators. In addition,
this report provides insights on the factors that are driving and restraining
the global autoimmune disease diagnostics market. Moreover, IGR-Growth Matrix
analysis given in the report brings an insight on the investment areas that
existing or new market players can consider.
The report provides insights into
the market using analytical tools such as Porter’s five forces analysis and DRO
analysis of autoimmune disease diagnostics market. Moreover, the study
highlights current market trends and provides forecast from 2017 to 2023. We
also have highlighted future trends in the autoimmune disease diagnostics
market that will impact the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight on the
market share of the leading players. Additionally, the analysis highlights rise
and fall in the market shares of the key players in the market.
Please Choose One of them.